Indian health insurer Niva Bupa files for Rs 3000 crore IPO

Published On 2024-07-02 06:00 GMT | Update On 2024-07-02 06:00 GMT

Bengaluru: Niva Bupa, an Indian health insurer, has filed for an initial public offering (IPO) aiming to raise up to 30 billion rupees (approximately $360 million), draft papers have revealed.

The company, predominantly owned by British United Provident Fund (Bupa), intends to issue fresh shares valued at up to eight billion rupees as part of the offering.

According to Reuters report, it aims to use the proceeds from that sale to strengthen its balance sheet and for operating expenses.

Existing shareholders Bupa Singapore Holdings and Fettle Tone, will sell shares up to 22 billion rupees, Niva Bupa added.

As of the end of fiscal 2024, the company's borrowings stood at 2.50 billion rupees, unchanged for the third straight fiscal. Its total income, which comprises net premium income, investment income and other income, rose 44% year-on-year.

ICICI Securities, Morgan Stanley, Kotak Mahindra Capital and Axis Capital were among the book-running managers to Niva Bupa's IPO.

The insurer is set to go public in India's booming IPO market.

Read also: Nephro Care India plans to raise Rs 35-40 crore via IPO

More than 100 companies have raised around $4 billion in IPOs so far this year, more than double the amount raised by this time last year, per LSEG data, with the domestic equity market at an all-time high on the prospect of healthy economic growth.

Niva Bupa Health Insurance (formerly known as Max Bupa Health Insurance) is one of the most trusted standalone health insurance partners.

Read also: Emcure Pharma set to launch IPO on July 3

Article Source : with inputs

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Desk Editor for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Indian health insurer Niva Bupa files for Rs 3000 crore IPO

Similar News